| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/18/2010 | WO2010081012A3 Disease control with tick phospholipase a2 |
| 11/18/2010 | WO2010078466A3 Sand fly salivary proteins with anti-complement activity and methods of their use |
| 11/18/2010 | WO2010077093A9 Composition for promoting hair growth or preventing hair loss comprising erythropoietin |
| 11/18/2010 | WO2010069605A3 Oxidized cardiolipin as a novel pro-inflammatory factor |
| 11/18/2010 | WO2010039533A3 Methods for predicting production of activating signals by cross-linked binding proteins |
| 11/18/2010 | WO2010033426A3 Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor |
| 11/18/2010 | WO2010017965A3 SOLID LIPID MICROCAPSULES CONTAINING hGH |
| 11/18/2010 | WO2010014541A3 Compositions and methods for treatment of hypercholesterolemia |
| 11/18/2010 | WO2010011890A4 Cancer peptide therapeutics |
| 11/18/2010 | WO2009151708A3 Peptide analogs of alpha-melanocyte stimulating hormone |
| 11/18/2010 | WO2009108390A3 Method for achieving desired glial growth factor 2 plasma levels |
| 11/18/2010 | WO2007133816A3 Methods of treating pain and inflammation in neuronal tissue using il-31ra and osmrb antagonists |
| 11/18/2010 | US20100292791 Fully synthetic implantable multi-phased scaffold |
| 11/18/2010 | US20100292669 Method and apparatus for in situ drug delivery during distraction osteogenesis |
| 11/18/2010 | US20100292456 Rna interference mediating small rna molecules |
| 11/18/2010 | US20100292453 Lectin compositions and methods for modulating an immune response to an antigen |
| 11/18/2010 | US20100292314 Anti-angiogenic compositions and methods of use |
| 11/18/2010 | US20100292308 Microrna molecules |
| 11/18/2010 | US20100292174 Caspase inhibitors in the treatment of infection-associated preterm delivery |
| 11/18/2010 | US20100292173 Wound Healing Compounds And Methods |
| 11/18/2010 | US20100292172 Peptide-Peptidase Inhibitor Conjugates and Methods of Using Same |
| 11/18/2010 | US20100292171 Competitive Regulation of Hepcidin mRNA by Soluble and Cell-Associated Hemojuvelin |
| 11/18/2010 | US20100292170 Methods for diagnosing and treating pelvic pain disorders via beta-catenin |
| 11/18/2010 | US20100292169 Methods and compositions for regulating hdac6 activity |
| 11/18/2010 | US20100292168 Protein Mixture and Use Thereof in the Preparation of a Product that is Intended for Oral or Enteral Administration |
| 11/18/2010 | US20100292167 C-met kinase binding proteins |
| 11/18/2010 | US20100292166 PHARMACEUTICAL COMPOSITION FOR TREATING MALIGNANT TUMORS CONTAINING HUMAN p31 GENES |
| 11/18/2010 | US20100292165 Treatment of an intestinal adenoma and/or adenocarcinoma by inhibition of notch pathway activation |
| 11/18/2010 | US20100292164 Dimerized peptide |
| 11/18/2010 | US20100292163 Antitumoral Compounds |
| 11/18/2010 | US20100292162 Socs-3 promoter methylation in cancer |
| 11/18/2010 | US20100292161 Polypeptides and methods of use |
| 11/18/2010 | US20100292160 Hla-a* 3303-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 11/18/2010 | US20100292159 Method of treatment or prophylaxis of inflammatory pain |
| 11/18/2010 | US20100292158 Compositions and Methods for Enhanced Pharmacological Activity of Compositions Comprising Peptide Drug Substances |
| 11/18/2010 | US20100292157 Combination Treatments for Alzheimer's Disease and Similar Diseases |
| 11/18/2010 | US20100292156 Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid, and uses thereof |
| 11/18/2010 | US20100292155 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 11/18/2010 | US20100292154 Protein profile for osteoarthritis |
| 11/18/2010 | US20100292153 Use of muramyl dipeptide (mdp) for treating inflammation |
| 11/18/2010 | US20100292152 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 11/18/2010 | US20100292151 Use of human cytokine receptor |
| 11/18/2010 | US20100292150 Treatment of Menorrhagia with Aromatase Inhibitor |
| 11/18/2010 | US20100292149 Modulation of the Neuroendocrine System as a Therapy for Motor Neuron Disease |
| 11/18/2010 | US20100292148 Targeted polylysine dendrimer therapeutic agent |
| 11/18/2010 | US20100292147 Identification of the hepcidin binding site on ferroportin |
| 11/18/2010 | US20100292146 Composite bone repair material |
| 11/18/2010 | US20100292145 Methods of regulating apoptosis |
| 11/18/2010 | US20100292144 Sustained delivery of exenatide and other peptides |
| 11/18/2010 | US20100292143 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application |
| 11/18/2010 | US20100292142 Novel neurotrophic factors |
| 11/18/2010 | US20100292141 Insulin nasal powder inhalation |
| 11/18/2010 | US20100292140 Antisense modulation of fibroblast growth factor receptor 4 expression |
| 11/18/2010 | US20100292139 Topical drug delivery using phosphatidylcholine |
| 11/18/2010 | US20100292138 Peptide Derived from Hepatitis C Virus |
| 11/18/2010 | US20100292137 Antibiotics and Methods For Producing Them |
| 11/18/2010 | US20100292136 Polymyxin derivatives and uses thereof |
| 11/18/2010 | US20100292135 INHIBITORS OF RecA ACTIVITIES FOR CONTROL OF ANTIBIOTIC-RESISTANT BACTERIAL PATHOGENS |
| 11/18/2010 | US20100292134 Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury |
| 11/18/2010 | US20100292133 Truncated glp-1 derivaties and their therapeutical use |
| 11/18/2010 | US20100292132 Use of insulin c-peptide, alone or in combination with glp-1, as a therapeutic agent |
| 11/18/2010 | US20100292131 Biomarkers and methods for diagnosing, predicting and/or prognosing sepsis and uses thereof |
| 11/18/2010 | US20100292130 Biological active proteins having increased in vivo and/or in vitro stability |
| 11/18/2010 | US20100292129 Methods and Compositions for Enhancing Proteasome Activity |
| 11/18/2010 | US20100291680 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission |
| 11/18/2010 | US20100291556 Isolated aebp1 genomic polynucleotide fragments from chomosome 7 and their uses |
| 11/18/2010 | US20100291222 Antioxidant nanosphere comprising [1,2]-dithiolane moieties |
| 11/18/2010 | US20100291220 Antibiotic formulation and method of treatment |
| 11/18/2010 | US20100291215 Drug delivery matrices to enhance wound healing |
| 11/18/2010 | US20100291212 Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use |
| 11/18/2010 | US20100291210 Novel lipid peptide and hydrogel |
| 11/18/2010 | US20100291196 Method of treatment of autism spectrum disorder with liposomal reduced glutathione |
| 11/18/2010 | US20100291194 Compositions and Methods for Inhibiting Expression of a Mutant Gene |
| 11/18/2010 | US20100291193 Immunogenic compositions comprising progastrin and uses thereof |
| 11/18/2010 | US20100291188 Periostin Inhibitory Compositions for Myocardial Regeneration, Methods of Delivery, and Methods of Using Same |
| 11/18/2010 | US20100291182 Drug-Loaded Fibers |
| 11/18/2010 | US20100291181 Therapeutic devices for patterned cell growth |
| 11/18/2010 | US20100291180 Nerve guidance tubes |
| 11/18/2010 | US20100291179 Composite biomaterial for controlled release of active ingredients |
| 11/18/2010 | US20100291178 Multi-phased, biodegradable and osteointegrative composite scaffold for biological fixation of musculoskeletal soft tissue of bone |
| 11/18/2010 | US20100291172 Sterile Autologous, Allogenic or Xenogenic Implant and the Method of its Production |
| 11/18/2010 | US20100291170 Novel therapies for chronic renal failure |
| 11/18/2010 | US20100291160 Pharmaceutical system for trans-membrane delivery |
| 11/18/2010 | US20100291153 Vaccines against bordetella pertussis based on lps glycosyltransferase mutants |
| 11/18/2010 | US20100291151 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor |
| 11/18/2010 | US20100291134 Truncated hepatitis c virus ns5 domain and fusion proteins comprising same |
| 11/18/2010 | US20100291127 Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| 11/18/2010 | US20100291126 Protein showing enhanced expression in cancer cells |
| 11/18/2010 | US20100291125 Eta-1 gene and methods for use |
| 11/18/2010 | US20100291122 Method for enhancing immune response with peptide |
| 11/18/2010 | US20100291121 Tumour-Specific Animal Proteins |
| 11/18/2010 | US20100291120 Peptides regulating the surface expression of the t cell receptor |
| 11/18/2010 | US20100291119 Alpha B crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis |
| 11/18/2010 | US20100291118 Class of Gamma Delta T Cells Activators and Use Thereof |
| 11/18/2010 | US20100291116 Microparticle comprising cross-linked polymer |
| 11/18/2010 | US20100291105 Agent for the treatment of malignant diseases |
| 11/18/2010 | US20100291100 Compositions And Methods For Screening And Using Compounds Antagonizing Spore-Surface Interactions |
| 11/18/2010 | US20100291099 Novel 27411, 23413, 22438, 23553, 25278, 26212, narc sc1, narc 10a, narc 1, narc 12, narc 13, narc17, narc 25, narc 3, narc 4, narc 7, narc 8, narc 11, narc 14a, narc 15, narc 16, narc 19, narc 20, narc 26, narc 27, narc 28, narc 30, narc 5, narc 6, narc 9, narc 10c, narc 8b, narc 9, narc2a, narc 16b, narc 1c, narc 1a, narc 25, 86604 and 32222 molecules and uses therefor |
| 11/18/2010 | US20100291098 Diabetic nephropathy therapies |
| 11/18/2010 | US20100291093 Antibody-mediated disruption of quorum sensing in bacteria |